Valuation (81%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 10.72 | N/A |
| PEG Ratio (TTM) | 5.12 | N/A |
| P/S Ratio (TTM) | 0.70 | N/A |
| P/B Ratio (TTM) | 2.12 | N/A |
| P/FCF Ratio (TTM) | 14.65 | N/A |
| Price to 5YR AVG Earnings Ratio | 19.81 | N/A |
| Price to 5YR AVG FCF Ratio | 14.31 | N/A |
Profitability (65%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 11.02% | N/A |
| ROE (TTM) | 20.70% | N/A |
| Net Profit Margin (TTM) | 6.57% | N/A |
| ROIC 5YR AVG | 20.80% | N/A |
Growth (87%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 8.00% | 281.03% | 179.95% |
| Revenue | 1.10% | 10.25% | 6.79% |
| Net Income | 5.88% | 287.41% | 183.20% |
| Cash Flow | 169.10% | 764.12% | 452.33% |
Health (74%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.42 | N/A |
| Quick Ratio (TTM) | 2.29 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | 70.26 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 4.15 | N/A |
| LTL to 5YR AVG FCF | 2.16 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.03% | N/A |